SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-045207
Filing Date
2021-02-16
Accepted
2021-02-16 17:13:51
Documents
2
Group Members
BLACKSTONE ALTERNATIVE SOLUTIONS L.L.C.BLACKSTONE CLARUS III L.L.C.BLACKSTONE GROUP INC.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I L.P.BLACKSTONE HOLDINGS II L.P.BLACKSTONE STRATEGIC OPPORTUNITY ASSOCIATES L.L.C.BSOF PARALLEL MASTER FUND L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G d128611dsc13g.htm SC 13G 203236
2 EXHIBIT A d128611dex99a.htm EX-99.A 16939
  Complete submission text file 0001193125-21-045207.txt   222345
Mailing Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O THE BLACKSTONE GROUP 345 PARK AVENUE NEW YORK NY 10154 2125835000
Blackstone Holdings I/II GP L.L.C. (Filed by) CIK: 0001464695 (see all company filings)

IRS No.: 260238303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address ONE BROADWAY 16TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 16TH FLOOR CAMBRIDGE MA 02142 617-949-2220
Praxis Precision Medicines, Inc. (Subject) CIK: 0001689548 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92098 | Film No.: 21640799
SIC: 2834 Pharmaceutical Preparations